NCT01631513: An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) |
|
|
| Withdrawn | 4 | 0 | US | Nucynta ER, Nucynta Extended Release | Janssen Scientific Affairs, LLC | Pain, Chronic Back Pain, Chronic Low Back Pain, Osteoarthritis Pain In The Hip or Knee | 08/12 | 04/13 | | |
